HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Constance K. Haan Fred H. Edwards Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Haan, C. K. Articles by Edwards, F. H. Search for Related Content PubMed PubMed Citation Articles by Haan, C. K. Articles by Edwards, F. H. Related Collections Valve disease

Ann Thorac Surg 2004;78:820-825
© 2004 The Society of Thoracic Surgeons

---

Original article: cardiovascular

Selecting patients with mitral regurgitation and left ventricular dysfunction for isolated mitral valve surgery

^a Division of Cardiothoracic Surgery, University of Florida, Jacksonville, Florida, USA
^b Division of Cardiology, University of Florida, Jacksonville, Florida, USA
^c The Outcomes Research and Assessment Group, Duke Clinical Research Institute, Durham, North Carolina, USA

Accepted for publication April 1, 2004.

^* Address reprint requests to Dr Haan, Division of Cardiothoracic Surgery, The Cardiovascular Center, UFHSC/J, 655 W Eighth St, Jacksonville, FL 32209, USA
connie.haan{at}jax.ufl.edu

BACKGROUND: American College of Cardiology/American Heart Association (ACC/AHA) Guidelines state that patients with an ejection fraction (EF) of 30% or less should not undergo mitral valve replacement for mitral regurgitation (MR). We sought to establish, using a national cardiac surgery database, whether patients with left ventricular dysfunction may safely undergo mitral valve surgery for MR, and if so, which ones.

METHODS: We queried the Society of Thoracic Surgeons (STS) National Database to identify patients who had isolated mitral valve replacement or repair for MR between 1998 and 2001. Mortality and morbidity outcomes were compared by EF category ( 30% vs > 30%), and observed mortality compared by EF group, stratified by predicted risk for mortality. A classification and regression tree (CART) model was then used to determine which patient characteristics contributed most to designate the high-risk patient.

RESULTS: Of the 14,582 patients who had mitral valve surgery, 727 had an EF of 30% or less and 13,855 had an EF of more than 30%. Observed mortality rates were higher for patients with an EF of 30% or less (5.4% vs 3.1%). However, for low-risk to medium-risk patients, mortality rates remained fairly constant across levels of EF. Mortality is notably increased in the high-risk patients (predicted risk > 10%). A classification tree identifies three key characteristics for high risk: age more than 75 years, renal failure, and emergent or salvage procedure.

CONCLUSIONS: When the predicted mortality risk is less than 10%, EF has minimal impact on operative mortality for mitral regurgitation. In contrast to the ACC/AHA Guidelines, our data show that operative risk for mitral valve surgery is not prohibitive for most patients with ventricular dysfunction.

This article has been cited by other articles:

				F. Nicolini and T. Gherli Alternatives to transplantation in the surgical therapy for heart failure Eur. J. Cardiothorac. Surg., February 1, 2009; 35(2): 214 - 228. [Abstract] [Full Text] [PDF]

				T Z Naqvi, A M Rafique, C Swerdlow, S Verma, R J Siegel, K Tolstrup, W Kerwin, J Goodman, D Gallik, E Gang, et al. Predictors of reduction in mitral regurgitation in patients undergoing cardiac resynchronisation treatment Heart, December 1, 2008; 94(12): 1580 - 1588. [Abstract] [Full Text] [PDF]

				P. Leszek, J. Korewicki, A. Klisiewicz, J. Janas, A. Biederman, A. Browarek, D. Charlemagne, and P. Trouve Reduced myocardial expression of calcium handling protein in patients with severe chronic mitral regurgitation Eur. J. Cardiothorac. Surg., November 1, 2006; 30(5): 737 - 743. [Abstract] [Full Text] [PDF]

				S. H. Rahimtoola The Year in Valvular Heart Disease J. Am. Coll. Cardiol., January 17, 2006; 47(2): 427 - 439. [Full Text] [PDF]

				J. M. Aranda Jr, G. W. Woo, R. S. Schofield, E. M. Handberg, J. A. Hill, A. B. Curtis, S. F. Sears, J. S. Goff, D. F. Pauly, and J. B. Conti Management of Heart Failure After Cardiac Resynchronization Therapy: Integrating Advanced Heart Failure Treatment With Optimal Device Function J. Am. Coll. Cardiol., December 20, 2005; 46(12): 2193 - 2198. [Abstract] [Full Text] [PDF]

				A. S. Shah, S. A. Hannish, C. A. Milano, and D. D. Glower Isolated Mitral Valve Repair in Patients With Depressed Left Ventricular Function Ann. Thorac. Surg., October 1, 2005; 80(4): 1309 - 1314. [Abstract] [Full Text] [PDF]